PAPER / ARXIV:2609.14709
Taoyong Cui , Xi Wang , Zonghang Li , Jinchao Ding , Lingsen You , Yuzhi Xu , Wanghan Xu , Fang Wu , Kejun Ying , Wanli Ouyang , Pheng Ann Heng , Ling Yang , Zhenfei Yin , Yingcheng Wu
RESUMO
Immune therapies act across cell-intrinsic programs, tissue ecosystems, and patient-specific immune states, yet most predictors address these scales separately. We used a governed evolutionary AI Scientist to construct the Immune World Model, an action-conditioned model that learns how interventions move immune states across cellular, tissue, and individual levels. The Immune World Model--building Scientist searched candidate architectures and workflows, and the resulting world model was frozen before independent confirmation. The frozen model generalized to unseen interventions and biological contexts, recovered intervention-specific cellular programs, integrated cell and tissue information to improve ecosystem and patient-response prediction, and forecast unseen perturbation combinations. Immune World Model--guided analysis then combined measured perturbations with cross-axis inference to nominate IL-36$\gamma$ plus SIRP$\alpha$ inhibition as a complementary-axis therapeutic hypothesis, whereas a governed self-correction audit rejected every screened cytokine pair. The Immune World Model provides a framework for multiscale immune simulation that connects AI Scientist-driven model construction, intervention forecasting, and the generation of prospectively testable therapeutic hypotheses.
NO MESMO MAPA